TABLE 2.
Intervention group(n = 57) | Control group(n = 56) | P | |
---|---|---|---|
Plasma LDL-C, mmol/L (mean ± SD) | 2.80 ± 0.89 | 2.78 ± 1.04 | NS* |
Plasma HDL-C, mmol/L (mean ± SD) | 0.94 ± 0.29 | 1.05 ± 0.31 | NS* |
Plasma triglycerides, mmol/L (mean ± SD) | 1.99 ± 1.03 | 2.25 ± 1.36 | NS* |
Plasma cholesterol, mmol/L (mean ± SD) | 4.61 ± 0.98 | 4.86 ± 1.15 | NS* |
TC:HDL-C ratio (mean ± SD) | 4.99 ± 1.27 | 4.96 ± 1.78 | NS* |
Patients on a lipid-lowering agent, % | 23.4 | 23.8 | NS† |
Patients with LDL-C <2.5 mmol/L, % | 38.2 | 43.1 | NS† |
Nonpaired Student’s t test;
χ2 test. HDL-C High-density lipoprotein cholesterol; LDL-C Low-density lipoprotein cholesterol; TC Total cholesterol